Истраживачи
Vuletić, Ana
Type
Date issued
Results 1-20 of 66
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Novel 1-benzhydryl piperazine scaffoldbased HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutation | Vuletić, Ana   ; Martinović, Mirjačić Katarina ; Srdić-Rajić, Tatjana ; Miletić, Nevena Tišma ; Đurić, Ana ; Nikolić, Katarina ; Ružić, Dušan ; Čavić, Milena | Conference Paper | Mp. category will be shown later |
| 2025 | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents | Beljkaš, Milan ; Ružić, Dušan ; Djurić, Ana ; Vuletić, Ana ; Nchugoua Tchiehe, Guilaine; Jallet, Corinne; Cadet-Daniel, Veronique; Arimondo, Paola B; Santibanez, Juan F. ; Srdić-Rajić, Tatjana ;
Nikolić, Katarina
; Oljačić, Slavica ; Petković, Miloš ; | Article | 22M22 |
| 2025 | Divide and Conquer-Targeted Therapy for Triple-Negative Breast Cancer. | Nedeljković, Milica ; Vuletić, Ana ; Mirjačić Martinović, Katarina | Article | 21M21 |
| 2025 | Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients | Mirjacic-Martinovic, Katarina M ; Vuletic, Ana M ; Tisma-Miletic, Nevena ; Nedeljkovic, Milica D ; Matkovic, Suzana ; Jurisic, Vladimir B | Article | 21M21 |
| 2025 | P24 The impact of TGFB1 and IFNG gene expression on progression of metastatic melanoma patients undergoing anti-PD-1 therapy | Luka Lisica ; Mališić, Emina ; Nedeljković, Milica ; Vuletić, Ana ; Petrović, Nina ; Matković, Suzana ; Martinović, Mirjačić Katarina | Conference Paper | Mp. category will be shown later |
| 2025 | Advantages and disadvantages of the assay for determining NK cell activity using radioactive chromium in clinical practice: our experience | Jurisic, Vladimir B ; Vuletic, Ana M ; Mirjacic-Martinovic, Katarina M ; Milovic-Kovacevic, Marijana M ; Radenkovic, Sandra S ; Knezevic, Sanja M; Markovic, Olivera B | Reviews | 21M21 |
| 2025 | The Role of Tumor Microenvironment in Triple-Negative Breast Cancer and Its Therapeutic Targeting | Vuletic, Ana ; Mirjacic-Martinovic, Katarina M ; Jurisic, Vladimir B | Article | 21M21 |
| 2024 | Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment | Beljkaš, Milan ; Petković, Miloš ; Ružić, Dušan ; Oljačić, Slavica ; Nikolić, Katarina ; Arimondo, Paola B; Srdić-Rajić, Tatjana ; Vuletić, Ana ; Jelić Mariokov Đurić, Ana | Conference Paper | Mp. category will be shown later |
| 2024 | Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design | Beljkaš, Milan ; Petković, Miloš ; Vuletić, Ana ; Đurić, Ana ; Santibanez, Juan F. ; Srdić-Rajić, Tatjana ; Nikolić, Katarina ; Oljačić, Slavica | Article | 21aM21a |
| 2024 | Abstract 1304: Employing widening funds to address inequity in cancer research - example of the STEPUPIORS collaborative rectal cancer project | Cavic, Milena ; Djuric, Ana ; Marinkovic, Mladen ; Stanojevic, Aleksandra ; Tanic, Miljana ; Bjelogrlic, Snezana ; Spasic, Jelena ; Damjanovic, Ana ; Crnogorac, Marija Djordjic ; Vuletic, Ana ;
Martinovic, Katarina Mirjacic
; Radulovic, Marko ; Stojanovic-Rundic, Suzana ; Krivokuca, Ana ; Jankovic, Radmila ; Castellvi-Bel, Sergi; Zoidakis, Jerome; Fijneman, Remond J.; | Conference Paper | Mp. category will be shown later |
| 2024 | Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer. | Vuletić, Ana ; Mirjačić Martinović, Katarina ; Spasić, Jelena | Article | 21aM21a |
| 2023 | L12 Circulating cytokines as potential biomarkers of disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Miletić, Nevena Tišma ; Matković, Suzana ; Gavrilović, Dušica; Jurišić, Vladimir ; Babović, Nada | Conference Paper | Mp. category will be shown later |
| 2023 | Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Tišma Miletić, Nevena ; Besu-Žižak Irina ; Milovanović, Jelena ; Matković, Suzana ; Jurisic, Vladimir | Article | 21M21 |
| 2023 | Circulating cytokine changes in BRAFwt MM patients during anti-PD-1 therapy | Mirjačić Martinović, Katarina ; Vuletić, Ana ; Tišma Miletić, Nevena ; Besu Žižak, Irina ; Milovanović, Jelena ; Matković, Suzana ; Jurišić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2023 | Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients | Mirjacic-Martinovic, Katarina M ; Vuletic, Ana M ; Tisma-Miletic, Nevena ; Nedeljkovic, Milica ; Babovic, Nada Lj ; Matkovic, Suzana ; Jurisic, Vladimir B | Article | 22M22 |
| 2023 | L12 Circulating cytokines as potential biomarkers of disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Miletić, Nevena Tišma ; Matković, Suzana ; Gavrilović, Dušica; Jurišić, Vladimir ; Babović, Nada | Conference Paper | Mp. category will be shown later |
| 2023 | Establishment of a first cancer Biobank at the Institute for Oncology and Radiology of Serbia –advantages, challenges and future perspective | Bjelogrlić, Snežana ; Tanić, Miljana ; Marinković, Mladen ; Spasić, Jelena; Đurić, Ana ; Rundić, Stojanović- Suzana ; Stanojević, Aleksandra ; Đorđić, Crnogorac Marija ; Mirjačić, Martinović Katarina ; Vuletić, Ana ;
Damjanović, Veličković Ana
; Radulović, Marko ; Janković, Radmila ; Zoidakis J; Fijneman R; Castellví-Bel S; Krivokuća Ana ; Čavić, Milena ; | Conference Paper | Mp. category will be shown later |
| 2023 | Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy | Mirjačić Martinović Katarina ; Vuletić Ana ; Tišma Miletić Nevena ; Matković Suzana ; Gavrilović Dušica; Ninković Aleksandra; Jurišić Vladimir ; Babović Nada | Article | 21M21 |
| 2023 | Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals | Čavić Milena ; Nešić Andrijana ; Mirjačić Martinović Katarina ; Vuletić Ana ; Besu Žižak Irina ; Tišma Miletić Nevena ; Krivokuća Ana ; Janković Radmila ; Gavrović -Jankulović Marija | Article | 21aM21a |
| 2023 | Antiproliferative effect of tubastatin A on vemurafenib sensitive and resistant A375 melanoma cells | Vuletić, Ana ; Đinović, Vuk; Miletić, Nevena Tišma ; Srdić-Rajić, Tatjana ; Martinović, Mirjačić Katarina | Conference Paper | Mp. category will be shown later |